Jason Hamilton

Jason Hamilton is currently the Global Head of Product Strategy for Cell and Gene Therapies at Genentech. With extensive experience in the biotechnology field, Hamilton has held significant roles at various organizations, including Vice President of Technical Operations at Legend Biotech and Analytical Project Leader at Novartis, where they executed the analytical strategy for the CTL019 CAR-T program. Hamilton completed a Doctor of Philosophy (PhD) in Neuroscience at the University of Rochester School of Medicine and Dentistry and a Bachelor of Science in Neuroscience at the University of Rochester. Previously, they served as a Postdoctoral Fellow at UC Irvine.